Oximio, South Africa, is delighted to announce that it has secured a resolution to the SAHPRA (South African Health Products Regulatory Authority) licence for the handling of medical cannabis. This...
SanaClis is expanding with a new office in Mexico! This strategic move allows us to better serve our clients and partners in the region, fostering stronger collaborations and accelerating the...
SanaClis is proud to announce that we are supporting Paralympic tennis team player Tomas Masaryk. As a company committed to making a positive impact on society, we are thrilled to...
SanaClis, a leading global clinical research organisation (CRO) and a prominent provider of clinical trial supply chain solutions, is excited to announce the launch of its state-of-the-art Clinical Trial Supply...
SOM Innovation Biotech, a biopharmaceutical company developing treatments for neurological orphan diseases with a proprietary AI-based drug discovery technology, has passed the milestone of 80% enrollment in its pivotal Phase...
APICES, a Spanish CRO with 15 years of experience in clinical research, has announced the integration of Kappa Santé, a French CRO with extensive experience in clinical research, which offers its...
We are thrilled to announce that SanaClis, a renowned leader in the pharmaceutical R&D industry, has become an esteemed partner of the Croatian Ski Association for a three-year period, which...
SanaClis is part of a highly exclusive group of companies in the Slovak Republic that have met the strictest economic evaluation criteria, according to the Dun & Bradstreet statical predictive...
Clariness today announces its support of YPrime’s ongoing commitment to enhance the patient and site eCOA experience by delivering insights from more than 2,000 patients in four countries, assessing patient...
Data privacy has become a significant concern for consumers in recent years, with high-profile data breaches and scandals making headlines on a regular basis. As individuals become more reliant on...